h-lys-trp-lys-oh

H-Lys-Trp-Lys-OH, a small molecule peptide, exhibits both antibacterial and antiviral activities.

H-Lys-Trp-Lys-OH acetate is a peptide with antibacterial and antiviral activities.

H-Lys-Trp-OH (KW) is an ACE inhibitory peptide with an IC50 of 7.8 μM [1].

Fmoc-Lys-OH hydrochloride is an alkyl-chain-based PROTAC linker and a non-cleavable ADC linker utilized in the synthesis of antibody-drug conjugates (ADCs).

Ac-DL-Trp-OH (N-Acetyl-DL-tryptophan) was study for its possible anti- inflammatory and antinociceptive activities from the extraction of a Turkish plant, Salsola grandis.

H-Tyr(3-I)-OH (3-Iodo-L-tyrosine) is an inhibitor of tyrosine hydroxylase (Ki = 0.39 M) and an intermediate in the synthesis of thyroid hormones

H-Abu-OH (L-α-amino-n-Butyric acid) , also known as (S)-2-aminobutanoic acid, homoalanine, 2-AABA, ethylglycine, or L-butyrine, is a member of the class of compounds known as L-alpha-amino acids. H-Abu-OH is a non-proteogenic amino acid that can be found in the human kidney, in liver tissues, and in most biofluids or excreta (e.g. feces, breast milk, urine, and blood). Within the cell, H-Abu-OH is primarily located in the cytoplasm. H-Abu-OH is biosynthesized by transaminating oxobutyrate, a metabolite in isoleucine biosynthesis. As a non-proteogenic amino acid, H-Abu-OH can be used by nonribosomal peptide synthases.

H-Lys(Tfa)-OH is an inhibitor of L-lysine cyclodeaminase.

H-D-cis-Hyp-OH (D-allo-Hydroxyproline) belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from a reaction of proline at the amino group or the carboxyl group, or from the replacement of any hydrogen of glycine by a heteroatom.

H-PRO-HIS-CYS-LYS-ARG-MET-OH acetate acts as antioxidant by reacting with active oxygen species such as superoxide and hydroxyl radicals.

Leu-Tyr-Asp-Lys is a tetrapeptide compound that can be used to study metabolism-related diseases.

Glu-urea-Lys is a molecular scaffold that targets PSMA and can be used as a prostate cancer imaging agent to study prostate-specific membrane antigens.

Lys-[Des-Arg9]Bradykinin acetate is an endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. 16-fold more potent than [Des-Arg9]-Bradykinin.

N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide that acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM for FPR1, 6.7 μM for FPR2, and 0.88 μM for FPR2-D2817.32G. This chemotactic peptide binds specifically to receptors on leukocyte membranes and its uptake can contribute to the quantitative assessment of neutrophils in localized inflammatory processes, independent of associated edema formation or microcirculatory compromise.

Lys-Bradykinin acetate is an endogenous bradykinin receptor agonist.

H-Ala-Ala-Tyr-OH acetate can be synthesized mutant peptides.

Lys-[Des-Arg9]Bradykinin,TFA is Endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. 16-fold more potent than [Des-Arg9]-Bradykinin.

H-Ile-Pro-Pro-OH acetate is a angiotensin-converting enzyme inhibitor (ACE) of milk-derived tripeptides.

N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH (TFA)) (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist and a potent chemoattractant for human neutrophils, with its radioiodinated form retaining full biological activity.

H-Ser-His-OH acetate is an endogenous metabolite hydrolysis cleavage activity.

Acetyl Ser-Asp-Lys-Pro is formed in bone marrow cells by enzymatic processing of thymosin β4. It inhibits the entry of pluripotent hemopoietic stem cells into S-phase of the cell cycle and protects against Ara-C lethality in mice.

H-Phe-Phe-OH is a dipeptide composed of two phenylalanine (an essential amino acid and precursor to tyrosine) units linked together.

Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) is an antibody-drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2). It contains the microtubule polymerization inhibitor DM1 as the active metabolite, which inhibits microtubule polymerization. It is commonly used in breast cancer research.

H-Gly-Pro-OH (Glycyl proline) is a dipeptide composed of glycine and proline, and is an end product of collagen metabolism

Phe-Lys(Trt)-PAB is a cathepsin-cleavable linker used in the development of antibody-drug conjugates (ADCs), serving as a crucial component for releasing therapeutic agents within targeted cells.

Tyrosylalanine (H-Tyr-Ala-OH), a dipeptide comprising L-tyrosine and L-alanine, is referenced in studies [1] [2].

H-Gly-Gly-Pro-OH (Glycyl-glycyl-L-proline) is a dipeptide composed of glycine and proline, and is an end product of collagen metabolism that is further cleaved by prolidase.

H-Trp-NH2.HCl ((2S)-2-amino-3-(1H-indol-3-yl)propanamide hydrochloride) is an endogenous metabolite that has been detected in various biological fluids, e.g. Urine and blood.

H-Val-Ala-OH (Valyl-alanine) is a dipeptide composed of L-Valine and L-Alanine residues, functioning as a metabolite.

H-Val-Pro-Pro-OH is an inhibitor of Angiotensin I converting enzyme (ACE)( IC50 : 9 μM).

N-ε-propargyloxycarbonyl-L-lysine hydrochloride (N6-((Prop-2-yn-1-yloxy)carbonyl)-L-lysine hydrochloride) is a modified amino acid for cancer therapy development.

H-ASP-PHE-OH (Aspartyl-phenylalanine) is used as pharmaceutical intermediates

H-Gly-Arg-Gly-Asp-Asn-Pro-OH (GRGDNP) is a integrin-ligand interactions inhibitor.

Boc-Gly-Tyr-Lys is a peptide.

Lys-P-1 is a bioactive chemical.

Fmoc-Lys(Me)3-OH Chloride, with catalog number T65200 and CAS number 201004-29-7, is a valuable organic compound for life sciences research.

H-Arg-Lys-OH is a dipeptide composed of L-arginyl and L-lysine residues.

H-N-Me-D-Ala-OH is a useful organic compound for research related to life sciences. The catalog number is T65369 and the CAS number is 29475-64-7.

MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT is a Camptothecin-linker and a drug-linker conjugate for antibody-drug conjugate (ADC).

H-Asn-Arg-OH is utilized in solid-phase peptide synthesis.

Ac-Val-Gln-aIle-Val-aTyr-Lys-NH2 exhibits serum stability and is non-toxic to neuronal cells, selectively inhibiting tau fibrillization over Aβ 42.

Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP is a cleavable linker used in the synthesis of antibody-drug conjugates (ADCs), innovative therapeutic agents that combine the targeting ability of antibodies with potent cytotoxic drugs.

Fmoc-Phe-Lys(Trt)-PAB is a cleavable linker utilized in the synthesis of antibody-drug conjugates (ADCs).

Fmoc-Lys(Boc)-Thr(psi(Me,Me)pro)-OH is a dipeptide.

Fmoc-D-Lys(Fmoc)-OH is a useful organic compound for research related to life sciences. The catalog number is T66832 and the CAS number is 75932-02-4.

H-D-Phe(3-F)-OH, with catalog number T67306 and CAS number 110117-84-5, is a valuable organic compound for research in life sciences.

Human glucagon-like peptide-1-(7-36)-Lys(Biotin) amide, a biotin-labeled variant of glucagon-like peptide-1-(7-36), is a gastrointestinal peptide known for its antidiabetogenic properties, including enhancing insulin secretion [1] [2].

H-D-Phe(4-CN)-OH is an important organic compound utilized in life sciences research, catalog number T65897 and CAS number 263396-44-7.

Cbz-Phe-(Alloc)Lys-PAB-PNP, a cleavable linker, is utilized in the design of antibody-drug conjugates (ADCs).

Lys-Phe-Glu-Arg-Gln promotes cytosolic protein degradation in serum-deprived human diploid fibroblasts [1].